---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-041636"
form_type: "8-K/A"
ticker: "INDP"
cik: "0001857044"
company_name: "Indaptus Therapeutics, Inc."
filed_at: "2026-09-05T01:55:25+00:00"
generated_at: "2026-09-08T10:05:11.222141+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Indaptus enters $100M ATM equity offering agreement with H.C. Wainwright

## Summary
- Amended and restated ATM agreement executed Aug 28, 2026, replacing June 1, 2022 pact with H.C. Wainwright.
- Company may sell up to $100M in common stock through Wainwright as sales agent or principal.
- Placement fee of 3.0% of gross sales proceeds for agent sales; no obligation to sell any shares.
- Prospectus supplement filed Aug 31, 2026, amended Sept 4, 2026 to update dilution disclosure.

## SEC filing metadata
- accession: 0001493152-26-041636
- form_type: 8-K/A
- ticker: INDP
- cik: 0001857044
- company_name: Indaptus Therapeutics, Inc.
- filed_at: 2026-09-05T01:55:25+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1857044/000149315226041636/0001493152-26-041636-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1857044/000149315226041636/form8-ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-041636
- JSON: https://secwatch.observer/filing/0001493152-26-041636.json
- Plain text: https://secwatch.observer/filing/0001493152-26-041636.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.